FR Doc E7-25038 [Federal Register: December 27, 2007 (Volume
72, Number 247)] [Notices] [Page 73368] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27de07-84]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated August 28, 2007 and published in the Federal
Register on September 10, 2007, (72 FR 51664), CIMA Labs, Inc.,
7325 Aspen Lane, Brooklyn Park, Minnesota 55428 made application
by letter to the Drug Enforcement Administration (DEA) to be
registered as an importer of Nabilone (7379), a basic class of
controlled substance listed in schedule II.
The company plans to import the basic class of controlled
substance for clinical trials and research.
No comments or objections have been received. DEA has
considered the factors in 21
U.S.C. 823(a) and 952(a)
and determined that the registration of CIMA Labs, Inc. to
import the basic class of controlled substance is consistent
with the public interest and with United States obligations
under international treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA has investigated CIMA
Labs, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has
included inspection and testing of the company's physical
security systems, verification of the company's compliance with
state and local laws, and a review of the company's background
and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a),
and in accordance with 21
CFR 1301.34, the above named company is granted registration
as an importer of the basic class of controlled substance
listed.
Dated: December 18, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E7-25038 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).